• While the test is based on DOT standards, it does not meet the DOT requirements for drug testing 49 CFR Parts 40 & 382
• FDA approved
• Rapid one-step urine screening test can be performed without the use of an instrument
• Split-specimen collection device – urine sample can be sent into the lab for confirmation testing
• Locking screw-top lid provides secure closure, prevents spills and ensures chain of custody
• Peel-off label covers temp strip, to be removed by collector, and prevents adulteration
• Includes a key requiring the collector to activate the test (collector activated vs. donor activated)
• Easy-to-read (and photocopy) results in minutes
• Each split urine drug test is expiration dated (18 months from date of manufacture)
• Price per box of 25 tests

Split drug test can be used for the simultaneous detection of the following drugs and their metabolites, but is not intended to be used for a drug test required by Part 382:

59938 – with adulterant parameters (pH, S.G., Cr, Ni, BI), CLIA waived and FDA approved
Cocaine (COC) 300 ng/ml
Amphetamine (AMP) 1000 ng/ml
Methamphetamine (mAMP) 1000 ng/ml
Marijuana (THC) 50 ng/ml
Opiates (OPI) 2000 ng/ml

59939 – with adulterant parameters (pH, S.G., Cr, Ni, BI), CLIA waived and FDA approved
Cocaine (COC) 300 ng/ml
Amphetamine (AMP) 1000 ng/ml
Marijuana (THC) 50 ng/ml
Opiates (OPI) 2000 ng/ml
Phencyclidine (PCP) 25 ng/ml

59971 – without adulterants, CLIA waived and FDA approved
Cocaine (COC) 300 ng/ml
Amphetamine (AMP) 1000 ng/ml
Methamphetamine (mAMP) 1000 ng/ml
Marijuana (THC) 50 ng/ml
Opiates (OPI) 2000 ng/ml

59972 – without adulterants, CLIA waived and FDA approved
Cocaine (COC) 300 ng/ml
Amphetamine (AMP) 1000 ng/ml
Marijuana (THC) 50 ng/ml
Opiates (OPI) 2000 ng/ml
Phencyclidine (PCP) 25 ng/ml

59973 – without adulterants, THC free, CLIA waived and FDA approved
Cocaine (COC) 300 ng/ml
Amphetamine (AMP) 1000 ng/ml
Methamphetamine (mAMP) 1000 ng/ml
Oxycodone (OXY) 100 ng/ml
Opiates (OPI) 2000 ng/ml

59974 – 9-panel drug test, without adulterants, THC free, FDA approved
Ecstacy (MDMA) 500 ng/ml
Oxycodone (OXY) 100 ng/ml
Amphetamine (AMP) 1000 ng/ml
Opiates (OPI) 2000 ng/ml
Benzodiazepines (BZO) 300 ng/ml
Methadone (MTD) 300 ng/ml
Barbiturates (BAR) 300 ng/ml
Methamphetamine (mAMP) 1000 ng/ml
Cocaine (COC) 300 ng/ml

Note: This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Liquid chromatography/mass spectrometry (LC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when non-negative (preliminary positive) results are indicated on the screening device.

Due to export restrictions, these medical devices cannot be shipped outside of the USA without written consent.